Mico BioMed Co. Ltd. (214610) - Total Liabilities

Latest as of September 2025: ₩7.88 Billion KRW ≈ $5.34 Million USD

Based on the latest financial reports, Mico BioMed Co. Ltd. (214610) has total liabilities worth ₩7.88 Billion KRW (≈ $5.34 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 214610 operating cash flow to assess how effectively this company generates cash.

Mico BioMed Co. Ltd. - Total Liabilities Trend (2015–2024)

This chart illustrates how Mico BioMed Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Check Mico BioMed Co. Ltd. (214610) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Mico BioMed Co. Ltd. Competitors by Total Liabilities

The table below lists competitors of Mico BioMed Co. Ltd. ranked by their total liabilities.

Company	Country	Total Liabilities
Edinburgh Investment Trust LSE:EDIN	UK	GBX122.27 Million
Park Ha Biological Technology Co., Ltd. NASDAQ:PHH	USA	$1.58 Million
Zenta Group Company Limited Ordinary Shares NASDAQ:ZGM	USA	$429.97K
Samyoung S&C Co. Ltd. KQ:361670	Korea	₩2.99 Billion
Armlogi Holding Corp. Common Stock NASDAQ:BTOC	USA	$133.96 Million
Greencore Group LSE:GNC	UK	GBX780.70 Million
SemiLEDS Corporation F:6LD1	Germany	€19.19 Million
Mason Capital Corporation KQ:021880	Korea	₩13.70 Billion

Liability Composition Analysis (2015–2024)

This chart breaks down Mico BioMed Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 214610 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.88	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.31	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.23	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Mico BioMed Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Mico BioMed Co. Ltd. (2015–2024)

The table below shows the annual total liabilities of Mico BioMed Co. Ltd. from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩28.58 Billion ≈ $19.37 Million	+14.38%
2023-12-31	₩24.99 Billion ≈ $16.93 Million	-37.24%
2022-12-31	₩39.82 Billion ≈ $26.98 Million	+9.34%
2021-12-31	₩36.42 Billion ≈ $24.68 Million	+142.82%
2020-12-31	₩15.00 Billion ≈ $10.16 Million	-37.53%
2019-12-31	₩24.01 Billion ≈ $16.27 Million	+30.16%
2018-12-31	₩18.45 Billion ≈ $12.50 Million	+41.64%
2017-12-31	₩13.02 Billion ≈ $8.83 Million	+130.32%
2016-12-31	₩5.65 Billion ≈ $3.83 Million	+0.74%
2015-12-31	₩5.61 Billion ≈ $3.80 Million	--

About Mico BioMed Co. Ltd.

KQ:214610 Korea Publishing

Market Cap

$13.00 Million

₩19.18 Billion KRW

Market Cap Rank

#26218 Global

#1955 in Korea

Share Price

₩2290.00

Change (1 day)

-2.35%

52-Week Range

₩2255.00 - ₩8470.00

All Time High

₩12100.26